| abstract |
New vaccine formulations against human papillomavirus (HPV) have increased long-term stability. The components of the formulation may include: virus-like particles (VLPs) absorbed on aluminum, a salt, non-ionic surfactant, and a buffer. The additional formulations also contain a polyanionic polymeric stabilizer and a salt, either in the presence or in the absence of buffering agents and detergent-ionic. |